about
Function, regulation and pathological roles of the Gab/DOS docking proteinsCombined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcomaEffects of simulated altitude (normobaric hypoxia) on cardiorespiratory parameters and circulating endothelial precursors in healthy subjectsVEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complexCrystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptorEnhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactomeStructural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase.The Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis.Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphataseAsef2 and Neurabin2 cooperatively regulate actin cytoskeletal organization and are involved in HGF-induced cell migrationhTID-1 defines a novel regulator of c-Met Receptor signaling in renal cell carcinomasEGFR/Met association regulates EGFR TKI resistance in breast cancerGrowth factors induce differential phosphorylation profiles of the Hrs-STAM complex: a common node in signalling networks with signal-specific propertiesAb-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activityAn uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in miceEssential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functionsCyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activationMet receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family membersMechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastomaThe transcription factor LSF: a novel oncogene for hepatocellular carcinomaAn overview of the c-MET signaling pathwayIdentification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcomaMET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibPAX3-FOXO1 fusion gene in rhabdomyosarcomaMicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma developmentMTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancerA genetic variant that disrupts MET transcription is associated with autismGenetic targeting of the kinase activity of the Met receptor in cancer cellsIntegrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergyHigh expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcomaScatter factor/hepatocyte growth factor in brain tumor growth and angiogenesisUnderstanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?Biomarker development in MET-targeted therapyClinical significance of MET in gastric cancerRecent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingHepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer ChallengeProgress toward overcoming hypoxia-induced resistance to solid tumor therapyDysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistanceMET inhibitors in combination with other therapies in non-small cell lung cancer
P2860
Q21245511-53F0895C-C7AA-421E-B72D-F42C3620FBA4Q21245750-2BC8833E-CC8D-49DB-81C9-0A68B8263257Q21284409-61A63C3D-FCDD-4526-8021-9CA3B82A56EDQ24293027-FC4D1118-E4D1-4D03-91ED-E42552EFB2AFQ24294589-0D9E4528-9E9E-4D7D-820C-DBC2E18CD790Q24294625-F1A5F575-3F62-4AB5-B2AE-0933B7B6B2E2Q24307789-B8A3CBBD-DD81-4807-B276-CD36D4910813Q24314397-E86134D9-B63A-4BA8-BB60-887D8083D2BCQ24316395-D8FA73BC-17EC-4129-81B1-29576A3DC0A0Q24317786-B8F07B8F-AADA-441E-8AA5-30767F8E1265Q24337462-921FB7C1-35CC-472E-90CA-3E6329E69329Q24338635-684C9EFB-1554-4C22-9847-1391857649ACQ24532853-FD662952-77B8-4A9B-82E3-76824BA1647BQ24546366-0EF143A6-63A5-47F4-AD8F-BE7F4090FDCFQ24561588-F38566CE-8C46-43C4-B41C-FA3ADC441E60Q24561624-4A341B4E-FA16-4312-9C25-E588FE4C924DQ24606703-7B876140-B0B5-48F7-A3C6-E27C2CFC6F10Q24606871-5B6C6936-5148-4DE2-876F-B3D861C6095CQ24607424-C136497B-FAB5-46A9-831F-D2E71718EF81Q24613885-71BFC954-376F-4525-8F49-D8C8491A278DQ24633986-B479C7BB-9E43-484E-8D50-67CB7AE58606Q24645410-6ED84406-4782-46BE-9431-DCC7B6B0FED5Q24646295-AA101737-EE87-40CB-9A7F-6119726E7822Q24646520-93884EDA-2BC3-4468-83FE-A7B9CFA01C70Q24648202-2141D088-F7AB-45CC-9376-7B6BDE5E5EC1Q24651422-182A7361-45D4-4CE3-8F29-EF0E3F6D069DQ24674115-072E707F-5B69-4870-B5AE-437CB30D5D6EQ24675200-5BCFDD46-9234-4ACB-89BB-DB27846AA10DQ24677103-FDFD6126-EB23-4381-8D69-8B19CFC4BEE4Q24681561-D9E0748B-B483-4C27-854A-D6FA8EBF140AQ24681915-55142AFB-99EB-48B0-A7A0-959F98E5A1A1Q24683896-E0161802-DFC5-42BA-9955-DFED9DFAFC57Q26748581-1F03A681-EF7D-4A5E-8D5F-AA635EE9E5BDQ26751332-40FB87F7-084C-4976-8015-338F6AA0043DQ26776190-384E8B18-292D-4D30-9D01-02A91394C6D7Q26778234-2A0A65AF-7603-4EF9-ACAE-74B50477B9F7Q26781273-6E587CA2-700F-4A16-9EF3-A2E47C769DE7Q26796405-3A19398D-984E-4FC3-849C-03276FB35785Q26799900-E7D2D714-F95C-4705-B394-E09C1C91228FQ26823203-F5A46B95-7B8C-4D31-A1BB-73B704053DEB
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Met, metastasis, motility and more
@ast
Met, metastasis, motility and more
@en
Met, metastasis, motility and more
@nl
type
label
Met, metastasis, motility and more
@ast
Met, metastasis, motility and more
@en
Met, metastasis, motility and more
@nl
prefLabel
Met, metastasis, motility and more
@ast
Met, metastasis, motility and more
@en
Met, metastasis, motility and more
@nl
P2093
P3181
P356
P1476
Met, metastasis, motility and more
@en
P2093
Carmen Birchmeier
Ermanno Gherardi
George F Vande Woude
Walter Birchmeier
P2888
P304
P3181
P356
10.1038/NRM1261
P407
P577
2003-12-01T00:00:00Z
P6179
1036162157